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Inconsistent treatment estimates from
mis-specified logistic regression analyses of
randomized trials
J.N.S. Matthewsa∗and N.H. Badib
When the difference between treatments in a clinical trial is estimated by a difference in means, then it is well known
that randomization ensures unbiassed estimation, even if no account is taken of important baseline covariates.
However, when the treatment effect is assessed by other summaries, e.g. by an odds ratio if the outcome is binary,
then bias can arise if some covariates are omitted, regardless of the use of randomization for treatment allocation
or the size of the trial. We present accurate closed-form approximations for this asymptotic bias when important
Normally distributed covariates are omitted from a logistic regression. We compare this approximation with ones
in the literature and derive more convenient forms for some of these existing results. The expressions give insight
into the form of the bias, which simulations show is usable for distributions other than the Normal. The key result
applies even when there are additional binary covariates in the model. Copyright c© 0000 John Wiley & Sons, Ltd.
Keywords: Asymptotic bias; baseline values; logistic regression; probit regression; randomized clinical
trial.
1. Introduction
Randomized trials are often analysed using a linear or generalized linear model, so that the treatment effect can be adjusted
for important baseline covariates. However, if some baseline variables cannot be measured, or if their importance is not
appreciated, then they will be omitted from the model. Randomization ensures that the estimate of the treatment effect is
unbiassed when relevant covariates are omitted from a linear model. This is a consequence of the unit-treatment additivity
in such models [1, chapter 5] and does not necessarily carry over to generalized linear models. Several non-linear models
for which unbiassed estimators are obtained, notwithstanding the omission of covariates, are identified in [2], who also
show that the important case of binary outcomes analysed using a logistic model is asymptotically biassed when covariates
are omitted.
Numerous authors have addressed the problem of the effect of the omission of covariates in logistic regression. In
biostatistical contributions an epidemiological perspective is, perhaps more common [3, 4, 5, 6, 7, 8], but some authors
do focus on randomized trials [2, 9, 10, 11]. Gail and colleagues [2] derive approximations for the asymptotic bias in the
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treatment estimator when all covariates other than the treatment indicator are omitted. The case of two general, scalar,
covariates, one of which is fitted and the other omitted is considered in [10, 8]. The main exposition in [10] assumes that
the covariates are independent but, as the authors explain, this restriction can be relaxed. In all these articles Taylor series
approximations are used to provide some indication of the size and direction of the bias, so the expressions derived are
necessarily restricted to small parameter values, although whether it is the parameter of the fitted or omitted covariate that
needs to be small varies between these contributions.
In this article we make use of the properties of the extended skew-normal distribution [12] and an approximation of the
logistic function by the probit to obtain expressions for the least false values [13, p.25] of the fitted covariates when other
covariates are omitted. No use of Taylor series approximations is required, so the expressions give excellent numerical
results for a wide range of parameter values and provide useful insight into the form the bias takes in a randomized
trial. Our main result applies to a logistic regression with a single binary covariate, which we usually take to indicate the
treatment allocation, and an arbitrary number of continuous covariates. The latter are assumed to follow a multivariate
Normal distribution but simulation results show that the results hold for a wider class of covariates. Explicit forms for the
asymptotic bias given in [9, 10] are derived for our case and compared with that found using the skew-Normal distribution.
Extensions to allow additional binary covariates is possible, although these extensions require further assumptions.
In the next section we present the expression for the least false values and in Section 3 related work is explored.
Extensions to allow additional binary covariates are discussed in Section 4 and some simulation results and numerical
examples are given in Section 5. In the final section the implications for the analysis of trials with a binary outcome are
discussed.
2. Least false values
Suppose that the random variable Y ∈ {0, 1} is related to a binary covariate T ∈ {−1, 1} and further covariates X1 and
X2, that have p and q dimensions respectively, by
Pr(Y = 1 | T,X1, X2) = expit(µ+ αT + βT1 X1 + βT2 X2) (1)
where expit(u) = exp(u)/[1 + exp(u)]. If the fitted model omits X2, i.e. if
Pr(Y = 1 | T,X1) = expit(µ+ αT + βT1 X1) (2)
is assumed to apply, then our model is mis-specified and the consequences for the maximum likelihood estimates (MLEs)
(µˆ, αˆ, βˆ1) are described by the theory of mis-specified models first outlined by White [14]. Briefly, as the sample size
increases the MLEs tend not to the ‘true’ values, as they would for a correctly specified model, but to the ‘least false’
(LF) values, (µˆ∗, αˆ∗, βˆ∗1). These are the values that minimise the Kullback-Liebler (KL) divergence between the fitted
model and the true model. The KL divergence is E(log[g(Y,X)/f(Y,X; θ)]), where g(Y,X) is the true joint density of
the response, Y , and covariates, X , and f(Y,X; θ) is the density under the assumed model: the expectation is taken with
respect to g(·, ·). The KL divergence has much in common with a measure of distance between densities, as it is positive
and vanishes only if g(Y,X) = f(Y,X; θ). In the present application, the LF values are the values of µ∗, α∗1, β∗1 such that
the model (2) is as close as possible, in the KL sense, to the model in (1). A succinct treatment can be found in chapter
2 of [13], where it is shown that the expected score statistic is zero at the LF values. This observation provides a way to
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obtain equations determining the LF values which, for the present application, are:
E[expit(µ∗ + α∗T + β∗T1 X1)] = E[expit(µ+ αT + β
T
1 X1 + β
T
2 X2)] (3)
E[T expit(µ∗ + α∗T + β∗T1 X1)] = E[T expit(µ+ αT + β
T
1 X1 + β
T
2 X2)] (4)
E[X1jexpit(µ
∗ + α∗T + β∗T1 X1)] = E[X1jexpit(µ+ αT + β
T
1 X1 + β
T
2 X2)], (5)
where X1j is the jth element of X1, j = 1, . . . , p and expectations are taken with respect to the joint distribution of
(T,X1, X2).
We consider the case when, conditional on T = t, X = (XT1 , XT2 )T follows a multivariate Normal distribution with
mean νt and dispersion Ω, t = −1, 1. In principle we could allow the dispersion to change with T but analytic progress
does not seem possible in this case. We also use νt,1, νt,2, Ω11, Ω22, Ω12 and Ω21 to denote the partition of νt and Ω
induced by the partition of X . There is no explicit form for the expectations in (3), (4) and (5) but if we approximate
the logit link with the probit, i.e. use expit(u) ≈ Φ(cu) where Φ(·) is the standard Normal distribution function and
c = 16
√
3/(15pi) [15, p.119], then the first two require the evaluation of integrals of the form ∫ Φ(ζTu+ κ)φp(u;ω,Ω)du,
while the last requires
∫
ujΦ(ζ
Tu+ κ)φp(u;ω,Ω)du, where φp(·;ω,Ω) denotes the density of a p-dimensional Normal
variable. Analytic forms are available for such integrals and perhaps are most easily found from expressions for the density
and expectation of the Extended Skew Normal (ESN) distribution [12]: these are reproduced in the Appendix and further
information can be found in the recent monograph by Azzalini and Capitanio [16]. Applying these results to the probit
approximations to (3), (4) and (5) gives the following
β∗1 ≈
β1 +Ω
−1
11 Ω12β2√
1 + c2βT2 Ω˜β2
(6)
µ∗ ≈ 1√
1 + c2βT2 Ω˜β2
[µ+ 12β
T
2 {(ν1,2 + ν−1,2)− Ω21Ω−111 (ν1,1 + ν−1,1)}] (7)
α∗ ≈ 1√
1 + c2βT2 Ω˜β2
[α+ 12β
T
2 {(ν1,2 − ν−1,2)− Ω21Ω−111 (ν1,1 − ν−1,1)}], (8)
where Ω˜ = Ω22 − Ω21Ω−111 Ω12, is the dispersion of X2 conditional on X1. Outline details of the derivation can be found in
the Appendix. To repeat, the only approximation required for the results in (6), (7) and (8) is that of a logistic by a probit,
which is well known to be highly accurate.
When T is the treatment indicator and X are baseline covariates from a randomized trial, then the assumption made
above, namely var(X | T = 1) = var(X | T = −1) is automatically satisfied and, additionally, ν1 = ν−1, so (8) implies
that the least false value of the treatment effect α is
α∗ ≈ α√
1 + c2βT2 Ω˜β2
=
α
q˜
, say. (9)
Apart from the degenerate cases when β2 = 0 or when the variation in X2 is wholly explained by that in X1, i.e. Ω˜ = 0,
(9) shows that the omission of relevant covariates means that the treatment estimator is biassed towards no effect.
Statist. Med. 0000, 00 1–16 Copyright c© 0000 John Wiley & Sons, Ltd. www.sim.org 3
Prepared using simauth.cls
Statistics
in Medicine J.N.S. Matthews and N.H. Badi
3. Relation with other work
3.1. No fitted covariates other than the treatment indicator
Gail and colleagues[2] considered the bias of treatment estimates for the case when there are no fitted covariates, i.e. the
fitted equation is simply
Pr(Y = 1 | T ) = expit(µ+ αT ),
as opposed to (2), and where the omitted covariates are not restricted to being Normally distributed. Finding µ∗ and α∗
amounts to solving equations (3) and (4) with X1 omitted. In [2] Taylor series expansions for small βT2 X2 were used to
obtain the approximate solution
α∗ − α ≈ − 12βT2 Ω22β2(expit(µ+ α)− expit(µ− α)). (10)
In [9, 10] a different approach was applied to the case when the true model has two scalar covariates, only one of which
is included in the fitted model. As in [2] no assumption of Normality was made. These authors also used a Taylor series
expansion but now applied to the fitted, rather than the omitted covariate. Using the notation in the present paper, and
taking T to be the fitted covariate, the approach in [10] noted that
α∗ = 12 [logit(pi
∗
1)− logit(pi∗−1)] = H(α) (11)
where pi∗k = E(expit(µ+ kα+ ξ)), with the expectation taken with respect to the distribution of ξ = βT2 X2. Strictly it is
the distribution of ξ conditional on T = k but as T is a randomization indicator, this coincides with the unconditional
distribution of ξ. Expanding H(·) about α = 0 [10] gives, in the case of logistic regression,
α∗ ≈ αH ′(0) = α pi
∗
0 − E[expit(µ+ ξ)2]
pi∗0 − pi∗20
, (12)
As in (9), this is closer to 0 than α because E[expit(µ+ ξ)2] > (E[expit(µ+ ξ)])2 = pi∗20 . Exact analytic evaluation of
H ′(0) is not possible but further use of the approximation expit(u) ≈ Φ(cu) and results due to DB Owen reproduced in
[16, p.236], allow (12) to be written as
α∗ ≈ α 2T (h, a)
Φ(h)Φ(−h) = α
T (h, a)
T (h, 1)
(13)
where h = c(µ+ βT2 ν,2)/
√
1 + c2βT2 Ω22β2, a = 1/
√
1 + 2c2βT2 Ω22β2 and ν,2 is the mean of X2. T (h, a) is Owen’s T
function [17], which is defined in the Appendix, where some pertinent properties are also described. From these we can
deduce: i) that α∗ in (13) is always closer to 0 than α; ii) as | h | increases, α∗ approaches α and iii) the largest attenuation
of α occurs when h = 0.
While (9) gives a bias in α that does not change with the mean of the covariates, this is not the case with (13). This is
most accessibly shown by plotting, for a series of values of q˜−1, T (h, a)/T (h, 1) against P = expit(µ+ βT2 ν,2), which is
a typical response probability: for most randomized trials P will be between 0.1 and 0.9. The figure shows that the bias
correction using (9) is slightly conservative relative to (13) for most values of P .
3.2. Covariates fitted in addition to the treatment indicator
The approach taken in [10], unlike that in [2], can be adapted to the case when the fitted model includes covariates X1 in
addition to the treatment indicator. For any givenX1 (11) still applies, but with the expectation E[expit(µ+ kα+ βT1 X1 +
ξ)] now taken with respect to the distribution of X2 given X1. Consequently the bias factor T (h, a)/T (h, 1) still applies
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Figure 1. Correction factor T (h, a)/T (h, 1) plotted against P = expit(µ+ βT
2
ν,2), for four alternative values of the correction factor q˜−1, namely 0.7 (solid line); 0.8
(dashed line); 0.9 (long-dashed line); 0.95 (dot-dash line). The horizontal lines are at the values of q˜−1
but with a = 1/
√
1 + 2c2βT2 Ω˜β2 and
h =
c[µ+ βT1 X1 + β
T
2 (ν,2 +Ω21Ω
−1
11 (X1 − ν,1))]√
1 + c2βT2 Ω˜β2
. (14)
This is of limited use because of the dependence on X1, but replacing X1 by its mean ν,1, so h = c(µ+
βT ν)/
√
1 + c2βT2 Ω˜β2, provides a workable alternative that can be compared with (9) when multiple covariates are fitted.
3.3. Probit regression
It is widely acknowledged that in practice logistic and probit regressions can seldom be distinguished in terms of their
fit to the data. As the present analyses have exploited the similarity of expit(u) and Φ(u) it is natural to consider the
use of probit regression as an alternative to logistic regression, i.e. to replace (1) and (2) with Pr(Y = 1 | T,X1, X2) =
Φ(µ+ αT + βT1 X1 + β
T
2 X2) etc. The least false values for the maximum likelihood estimators from a probit regression
are essentially those in (6), (7) and (8), but with denominator
√
1 + βT2 Ω˜β2 in place of
√
1 + c2βT2 Ω˜β2, although the
justification of this result is slightly different - see the Appendix for details. Consequently
α∗ =
α√
1 + βT2 Ω˜β2
(15)
is an exact expression for the asymptotic bias in the treatment effect that arises when some covariates are omitted from a
probit regression with a treatment indicator and Normal covariates.
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Probit regression was also considered in [2] and [10]. The probit version of (10) is α∗ ≈ α(1− 12βT2 Ω22β2). The bias
term given in [10] for H ′(0) for the probit case is E(φ[Φ−1(pi0)])/φ(Φ−1[E(pi0)]), where φ(·) is the standard Normal
density. If the true model includes both X1 and X2, then when X2 is omitted the probit analogue of (11) applies and the
bias factor can be evaluated at pi0 = pi∗0 = Φ(µ+ βT1 X1 + ξ), with X1 fixed at an arbitrary value and expectations taken
over the distribution of X2 conditional on X1. The denominator of H ′(0) is φ(h/c), with h as in (14) and the numerator is
E[φ(µ+ βT1 X1 + ξ)]. This last expectation has an analytic solution leading to
H ′(0) =
E(φ[Φ−1(pi0)])
φ(Φ−1[E(pi0)])
=
φ(h/c)√
1+var(ξ)
φ(h/c)
=
1√
1 + βT2 Ω˜β2
.
This coincides with the result from [2] for small β2 and is the same correction factor as obtained from the use of the
skew-Normal distribution. The derivation in [10] assumes that α is small and our derivation of the above expression has
assumed that the covariates have a multivariate Normal distribution. In all cases the bias correction for probit regression,
unlike logistic regression, depends only on the conditional variance of the omitted variables and their associated regression
coefficients, and not on any measure of location.
4. Extensions of the model
The analysis presented thus far applies to a model where, apart from a binary treatment indicator, the covariates are
assumed to be continuous. It is often the case that in clinical trials some baseline variables are categorical. While such
variables may have more than two categories, they would usually be included in a linear predictor through dummy
variables, so there is no loss in assuming that categorical covariates are binary. The values of the binary treatment indicator
are assigned by randomization, so are independent of the values of the other covariates, a feature that would not be shared
by a general binary covariate.
If the model in (1) were extended to include a single non-treatment binary covariate, B ∈ {−1, 1}, as in
Pr(Y = 1 | T,B,X1, X2) = expit(µ+ αT + γB + βT1 X1 + βT2 X2), (16)
then the foregoing analysis of the effect of omittingX2 from the fitted model can be adapted to this case. In this model, as in
Section 2, T is a binary indicator of the randomized treatment, so is independent ofB andX . Consequently the parameters
defining the distributions ofB andX are unaffected by the value of T and we take Pr(B = b) = θb and E(X | B = b) = νb,
b = −1, 1, but continue to assume that the variance is unaffected by the value of B, i.e. var(X | B = b) = Ω.
Under these assumptions it follows that β∗1 is as in (6) and
α∗ ≈ α√
1 + c2βT2 Ω˜β2
γ∗ ≈ γ +
1
2β
T
2 ([ν1,2 − ν−1,2]− Ω21Ω−111 [ν1,1 − ν−1,1])√
1 + c2βT2 Ω˜β2
µ∗ ≈ µ+
1
2β
T
2 ((ν1,2 + ν−1,2)− Ω21Ω−111 (ν1,1 + ν−1,1))√
1 + c2βT2 Ω˜β2
.
where νb,1, νb,2 is the partition of νb corresponding to the partition of X into X1 andX2. The above results are exact for
probit regression, provided that the factor c2 is omitted from the denominator.
The above argument can be extended to several arbitrary binary covariates, B1, . . . , BK but only at the expense of
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rather restrictive assumptions about the form of E(X | B1, . . . , BK). However, for the case when the binary covariates
are independent of the Normal covariates, the arguments developed in this article can be applied if some of the Normal
covariates are omitted. This would arise if there were K − 1 dummy variables describing random allocation to K > 2
treatments, or if, e.g., binary variables T1 and T2 described the main effects in a randomized trial with a 2× 2 factorial
treatment structure. In these cases the omission of some Normal covariates leads to the log odds ratios for the treatments
being attenuated as in (9).
5. Some numerical results
5.1. Assessment of the accuracy of the approximations
The simulation results in Table 1 assess the accuracy of the forms of α∗ for the logistic regression given in equations (9),
(10) and (13), with the last adapted as in (14) as necessary. The simulated value is found by fitting the reduced model to a
sample of size 2× 106 simulated from the full model: all calculations were performed in R , version 3.10 [18]. Three cases
are presented: in the first the true model has two Normal covariates, neither of which is fitted, while in the second model
only one of these covariates is omitted. The third model has five covariates, three of which are omitted. In all cases the
Normal covariates have mean 0 and unit variance and correlations are 0.5. In the first half of Table 1 all βk = 0.5 and in
the remainder all βk = 2. The consequence of varying the size of the treatment effect is assessed by considering α = 0.5
and α = 1.5. It is important that the simulations correspond to realistic models, with outcome probabilities taking values
that are appropriate for a clinical trial. From (1) we find that
Pr(Y = 1 | T = ±1) ≈ Φ
(
c(µ± α+ βT ν)√
1 + c2βTΩβ
)
,
so if µ is chosen so that µ+ βT ν = 0 then the outcome probabilities will be around 0.5.
Table 1 shows that when α = 0.5 and βk = 0.5, all methods perform reasonably when no Normal covariates are fitted,
with that from (13) doing best. When some Normal covariates are fitted, Gail’s method is not applicable but the proposed
extension to (13) does well. The method based on the skew-Normal approximation is conservative, as would be predicted
from Figure 1 for response probabilities around 0.5. When the βk are larger Gail’s method fails, as would be anticipated
from its derivation. The method due to Neuhaus and colleagues performs better than the skew-Normal factor when no
Normal covariates are fitted, but the skew-Normal does better when the fitted model contains some Normal covariates.
The method leading to (13) assumes that α is small and the last two columns of Table 1 show that for α = 1.5 the skew-
Normal approximation is again better when Normal covariates are fitted and performs better relative to the method of
Neuhaus et al. than it did for the smaller value of α.
The results in Table 1 apply to outcome probabilities around 0.5, as the covariates have zero mean and µ = 0 throughout.
Table 2 investigates the situation as outcome probabilities become larger, with µ = 2 and µ = 4 also being considered.
When data are generated by (1) and a logistic model is fitted, then the left hand columns of Table 2 show that α∗ increases
and the bias decreases as µ increases. This feature is well captured by the method of Neuhaus et al. and, for small βk,
by Gail’s method, but is ignored by the approximation (9), which clearly does not depend on µ. If the data are generated
not from (1) but from the probit version, as described in section 3.3, and a probit regression is fitted, then matters are
quite different and the simulated values of α∗ are unaffected by changes in µ. The lack of dependence of (15) on µ is now
appropriate and the results in the right hand part of Table 2 confirm that the skew-Normal and Neuhaus methods are exact.
This difference between logistic and probit regressions does not appear to be widely appreciated.
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p = 0, q = 2 p = 1, q = 1 p = 2, q = 3
α = 0.5 βk = 0.5
Numerical 0.433 0.482 0.308
Skew-Normal 0.446 0.485 0.330
Gail’s method 0.408 - -
Neuhaus et al. 0.434 0.481 0.309
α = 1.5 βk = 0.5
Numerical 1.307 1.447 1.328
Skew-Normal 1.337 1.454 1.337
Gail’s method 1.262 - -
Neuhaus et al. 1.302 1.442 1.302
α = 0.5 βk = 2
Numerical 0.206 0.347 0.227
Skew-Normal 0.220 0.350 0.220
Gail’s method -0.970 - -
Neuhaus et al. 0.202 0.330 0.202
α = 1.5 βk = 2
Numerical 0.619 1.045 0.677
Skew-Normal 0.661 1.051 0.661
Gail’s method -2.311 - -
Neuhaus et al. 0.605 0.990 0.605
Table 1. Values of α∗ computed using simulation (sample of size 2× 106) and the three approximations given in equations
(9), (10) and (13), for various values of the regression parameters. The Normal covariates have mean 0, unit variance and
pairwise correlation of 12 . The number of fitted Normal covariates is p and the number omitted is q: throughout µ = 0.
p = 0, q = 2; α = 0.5, βk = 0.5
Logistic regression Probit regression
µ = 0 µ = 2 µ = 4 µ = 0 µ = 2 µ = 4
Numerical 0.433 0.455 0.488 0.378 0.377 0.372
Skew-Normal 0.446 0.446 0.446 0.378 0.378 0.378
Gail’s method 0.408 0.460 0.493 0.313 0.313 0.313
Neuhaus et al. 0.434 0.452 0.482 0.378 0.378 0.378
p = 0, q = 2; α = 0.5, βk = 2
Logistic regression Probit regression
µ = 0 µ = 2 µ = 4 µ = 0 µ = 2 µ = 4
Numerical 0.207 0.213 0.231 0.139 0.138 0.140
Skew-Normal 0.220 0.220 0.220 0.139 0.139 0.139
Gail’s method -0.971 -0.139 0.390 -2.50 -2.50 -2.50
Neuhaus et al. 0.202 0.208 0.227 0.139 0.139 0.139
p = 2, q = 3; α = 0.5, βk = 0.5
Logistic regression Probit regression
µ = 0 µ = 2 µ = 4 µ = 0 µ = 2 µ = 4
Numerical 0.437 0.445 0.458 0.378 0.378 0.379
Skew-Normal 0.446 0.446 0.446 0.378 0.378 0.378
Neuhaus et al. 0.434 0.452 0.482 0.378 0.378 0.378
Table 2. Values of α∗ computed using simulation (sample of size 2× 106) and the approximations, for both logistic and
probit regression, for different locations of the linear predictor. The Normal covariates have mean 0, unit variance and
pairwise correlation of 12 . The number of fitted Normal covariates is p and the number omitted is q.
5.2. Assessment of the effect of departures from Normality
Some simulations were carried out to assess the effect of non-Normality on the performance of the expressions for α∗ in
(9) and (13). Two types of departure were considered. The effect of a symmetric non-Normal distribution was assessed
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by generating X from a central multivariate t-distribution with 4 degrees of freedom, while the effect of skewness was
assessed using the log-Normal distribution. In the latter case X was derived from a bivariate Normal variable W with zero
mean. To assess the effect of skewness in the fitted or omitted variable or both, three types of model were considered,
with (X1, X2) taken as, respectively, (exp(W1)′,W2), (W1, exp(W2)′) and (exp(W1)′, exp(W2)′), where as usual X1
is the fitted covariate and X2 is omitted and ′ denotes centring to zero mean. The parameters of the t and log-Normal
distributions were chosen to give X1, X2 unit variance and correlation close to 12 , which implies that the skewness of the
log-Normal variables are 2.84. In all simulations µ = 0, with βk = 0.5 or 2 and α = 0.5 or 1.5, and one scalar covariate is
fitted and one omitted. The correction factors q˜−1 and T (h, a)/T (h, 1) both depend solely on the mean and dispersion of
the Xis, so these will be the same for all of the above models.
α = 0.5, βk = 0.5 α = 1.5, βk = 0.5 α = 0.5, βk = 2 α = 1.5, βk = 2
X bivariate t, 4 df 0.484 1.456 0.376 1.129
X = (exp(W1),W2) 0.479 1.441 0.352 1.061
X = (W1, exp(W2)) 0.488 1.460 0.403 1.194
X = (exp(W1), exp(W2)) 0.481 1.452 0.375 1.131
Skew-Normal 0.485 1.454 0.350 1.051
Neuhaus et al. 0.481 1.442 0.330 0.990
Table 3. Values of α∗ computed using simulation (sample of size 2× 106) and the two approximations given in equations
(9) and (13), for various values of the regression parameters. The covariates have a multivariate t distribution with 4 df or
are a mixture of Normal and log-Normal variables. In each case one covariate is fitted and one omitted, in addition to the
treatment indicator: throughout µ = 0. The approximations below the line apply to all the cases above it.
From Table 3 we see that for smaller βk the predictions of bias provided by (9) and (13) remain accurate even when
the covariates have non-Normal distributions. For larger values of βk, α∗ tends to be closer to α for these non-Normal
covariates than for Normal covariates. However, it should be noted that in this context βk = 2 is a large coefficient for a
covariate with unit variance and will seldom be encountered in practice.
5.3. Examples: the SNAP trial and the Mayo Clinic PBC trial
No direct evaluation of the above results is possible as they are all expressed in terms of parameters. However, some
practical indication of the size of the asymptotic bias, and how this changes with the included covariates, can be provided
by substituting estimates for the parameters from relevant studies.
The Scottish and Newcastle anti-emetic pre-treatment for paracetamol poisoning study (SNAP) [19] trial was designed
to assess ways to reduce adverse effects in the treatment of paracetamol poisoning. The trial used a 2× 2 design, comparing
i) the standard versus a modified N-acetylcysteine (NAC) regimen and ii) pre-treatment with an anti-emetic (ondansetron)
or placebo. The primary outcome was binary, namely whether or not the patient retched or vomited within two hours
of the initiation of NAC therapy. In the trial report [20] odds ratios adjusted for stratification variables were reported.
The stratification variables were all binary, assessing the timing and amount of paracetamol ingestion and risk factors for
hepatotoxicity. For illustration of the methods used in this paper the data have been re-analysed, replacing the stratification
variables by related continuous covariates. These are the concentration of paracetamol in the blood at presentation (mg/L)
and two measures of liver function, namely gamma glutamyl transferase (GGT) and alanine aminotransferase (ALT), both
in IU/L: the liver enzyme concentrations were logged before analysis.
The dispersion matrix of the three baseline covariates, based on the 217 patients in the trial, was used as Ω and β was
taken to be the estimated regression coefficients from the full logistic regression. The correlations, standard deviations and
estimated regression coefficients are shown in Table 4.
The values of inflation factors, i.e. the amount by which α exceeds α∗, namely q˜ and T (h, 1)/T (h, a) are shown in
the left hand part of Table 5 for a sequence of fitted models. Initially only the treatment indicators are fitted and the
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βk paracetamol conc. log GGT log ALT
paracetamol conc. 0.0054 85.34
log GGT -0.873 -0.093 0.812
log ALT 0.660 -0.150 0.448 0.686
Table 4. The correlations obtained from the dispersion matrix for the three continuous covariates chosen from the SNAP
trial, with standard deviations on the diagonal and regression coefficients in the second column
SNAP Trial PBC Trial
Included covariates q˜ T (h, 1)/T (h, a) Included covariates q˜ T (h, 1)/T (h, a)
None 1.104 1.129 None 1.289 1.346
+ log GGT 1.056 1.070 + log bilirubin 1.034 1.042
+ paracetamol 1.028 1.035 + log alkaline phosphatase 1.012 1.014
Table 5. The values of q˜, cf. (9), and T (h, 1)/T (h, a), cf. (13), for a series of increasing models for both the SNAP and
PBC trials
paracetamol concentration and liver function enzymes are omitted.
The first row of Table 5 shows that the treatment effects had all three of these covariates been included, the so-called
full conditional effects, are 13% larger than the marginal effects. The full conditional effects are about 7% larger than
those that would be found from a model which included just log GGT in addition to the treatment effects. Also adding
paracetamol to the model reduces the discrepancy to around 3%. The order in which covariates are added matters - the
full conditional effects are around 9% larger than those from a model with just paracetamol. These figures relate to (13),
those from (9) are slightly smaller.
An example in which the difference between marginal and conditional estimates is even more pronounced is the trial
comparing penicillamine with placebo for the treatment of primary biliary cirrhosis (the PBC trial) [21], with the data given
in [22]. While the primary endpoint is a survival time, an illustration of the methods in the current paper is provided by a
secondary analysis of end-of-study mortality. This illustrative analysis considers a full model which includes a treatment
indicator and the logarithms of the baseline concentrations of bilirubin (mg/dl), alkaline phosphatase (AP) (IU/L) and
urinary copper excretion (µg/day). It is shown in the right hand part of Table 5 that the treatment effect, estimated from
a model with all three covariates, is around 30-35% larger than the marginal estimate. However, once account is taken of
bilirubin, the other two covariates have little additional effect. If either of the covariates other than bilirubin were fitted
first, the change in the inflation factor is far less marked (to 1.216 with copper and to 1.142 for AP).
6. Discussion
One of the most widely cited instances of the effect of omitting a covariate is Simpson’s paradox [23], in which the
effect of a binary covariate can be reversed when a second binary covariate is taken into account. This phenomenon was
thoroughly investigated and set in more general contexts by Samuels [24]. The notion of Association Reversal (AR) was
introduced and the relation between AR and the Amalgamation Paradox (AMP) defined by Good and Mittal [25], where
conditioning on a second covariate significantly alters the relationship between the outcome and the first covariate, was
discussed. Samuels shows that, in general, omitting a covariate from a logistic regression can lead to AR. In our application
this would amount to α and α∗, and/or β∗1 and β1 having opposite signs. Our analysis, as shown by (6), (7) and (8) confirms
this. It also confirms Samuel’s observation that if the true coefficient of the omitted variable vanishes, i.e. β2 = 0, then
AR cannot occur and the AMP does not apply. For β2 6= 0 our equations also confirm, and quantify, the result that if the
fitted and omitted covariates are independent, then AR cannot occur but that the AMP is inevitable. Independence of the
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fitted and omitted covariates implies ν1,2 = ν−1,2 and Ω12 = 0, so the signs of α and α∗, and of β1 and β∗1 , must coincide.
However, both will be shrunk towards zero because Ω˜ does not vanish when Ω12 = 0. As Samuels points out, this is in
contrast to the situation for linear regression, where independence of fitted and omitted covariates prevents the AMP (and
hence AR). These properties are related to the non-collapsibility of the odds ratio, as discussed in [26, 27].
A consequence of this observation is that if a covariate, T , is independent of all other covariates in the model, then in
a linear regression the expectation of the estimator of its coefficient, E(αˆ), will be unaffected whatever other covariates
are included. This is of fundamental importance for estimation of the treatment effect in a randomized trial, where the
act of randomization ensures that the treatment indicator T is independent of the other baseline covariates. The reasons
for taking account of baseline covariates are summarised in a review of covariate adjustment[28] and the first advantage
adduced is that an adjusted analysis can correct for imbalance between treatment groups in prognostic covariates that
arise despite randomization. Although in a given trial adjusted and unadjusted analyses can produce different values for
αˆ, they ultimately estimate the same quantity because the expectation of αˆ over the joint distribution of the covariates and
response is always α.
As has been widely recognized[11, 29, 30, 31, 32, 33], this situation does not carry over to randomized trials with a
binary outcome when logistic regression is used to adjust for baseline covariates. In this case the AMP obtains and the
estimator of the treatment effect, αˆ, has an expectation that depends on which baseline variables are included and which
are excluded from the analysis, so there is no longer a single, unambiguous treatment effect. The marginal treatment odds
ratio ignores baseline covariates and is found from fitting a logistic model which includes only T and is therefore averaged
over all the baseline covariates that affect the outcome: it is also referred to as the population averaged effect and has the
advantage of being unambiguously defined. However, one of the advantages of including appropriate baseline covariates
adduced by Yu and colleagues [28] is that it provides a conditional treatment estimate that is clinically more relevant
because, by taking account of the different characteristics of patients, it gives a more pertinent comparison: see [11] and
Senn in discussion of [34]. However, when obtained by logistic regression it is not uniquely defined, which is something
triallists could find unsettling as the aim of a clinical trial is often thought to be to estimate the treatment effect.
Indeed, the multiplicity of possible treatment effects has implications for nomenclature. The present paper has used the
term asymptotic bias, occasionally shortened to bias, to refer to the differences between the parameters that purport to
measure the treatment effect. Although this terminology is in keeping with the other contributions to the field, it is rather
misleading because it implies that there is a single true effect, with respect to which the others are biassed. The marginal
treatment odds ratio is shrunk towards zero relative to the conditional ones, as shown by (9), as indeed are any conditional
estimates relative to that based on a superset of the covariates. As such the term ‘attenuation’, as previously suggested
[11], is probably preferable to bias.
While the qualitative effect on the treatment estimator of including more baseline variables in a logistic regression has
been appreciated for some time, the current paper provides a quantitative assessment of the effect. When planning a trial
either (9) or (13) will provide the triallist with some indication of the potential effect on the treatment estimate of including
various sets of covariates in a logistic regression. Strictly, the attenuation factors in (9) and (13) assume that the covariates
are Normally distributed but as shown in Sections 4 and Section 5.2, the formulae are useful more widely. Table 5 shows
that successively including log GGT and paracetamol each result in similar changes in the treatment effect and that it may
be useful to ensure that both are included in an analysis. On the other hand, in the PBC trial, once the effect of bilirubin
has been taken into account, there is little to be gained by including further variables. In general, if the triallist can a priori
identify a set, S, of covariates such that further additions to the set cause only small changes in q˜, then if variables in S are
always included in the analysis the range of conditional treatment estimators that might arise from further modification to
the model may not differ to any material extent.
How baseline covariates should be selected for trials has been the subject of much discussion, e.g. [32, 35, 36, 37, 38],
and the general conclusion is that ideally the selection should be made a priori. While it is conceded that this may not
always be practical [29], it would be wise to try to make the assessment of which covariates to include on the basis of
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pilot data rather than data from the trial itself. Given a set of covariates, the investigator can use (9) to assess how the
conditional treatment effect changes with which of these covariates is selected. However, conclusions drawn on this basis
can be undermined by the existence of an unknown covariate which has an important effect on the outcome and is not
closely related to the known covariates. This would not be a serious issue for trials analysed using a linear regression
because randomization provides protection against the untoward influence of unknown covariates. However, this benefit
of randomization may be less valuable for binary outcomes analysed using a logistic regression.
A further reason for recommending the use of baseline covariates [28, 32, 39] is to increase the power of an analysis,
because taking account of highly prognostic covariates will markedly reduce the residual variance. Variables which have
had a role in the stratification of the treatment allocation have a special status because these variables need to be included
if a correct estimate of variance is to be obtained [32, 38][40, pp. 601-2]. The scope of such recommendations is often not
precisely specified, although the arguments behind them are usually rehearsed in terms of a linear regression. However,
the reduction in the standard error of the treatment estimator which occurs for a linear regression is known not to apply
to logistic regresssion [5, 11]. Nevertheless, including prognostic baseline covariates in a logistic regression does tend to
increase the power of the study [41, 42], presumably because the increase in standard error due to the covariates is slight
compared with the inflation of the treatment effect implied by (9). However, both these articles based their conclusions on
simulation studies in which a single covariate covariate was considered and the increase in power when the covariate was
included was most noticeable if it was highly prognostic, so that the attenuation in (9) was marked. Whether including
further covariates would lead to an increase in power is moot, because the consequent inflation in the treatment effect may
no longer outweigh the increase in standard error. It should also be remarked that the rationale for the automatic inclusion
of stratification variables in a logistic regression is less apparent than it is for a linear regression and might usefully be
investigated further.
In practice an investigator will often plan a trial on the basis of the power of an unadjusted analysis, although even here
a realistic value for the odds ratio under the alternative may need to be judged in the light of the preceding discussion. The
inclusion of an important baseline covariate, or covariates, may increase the power of the study but the size of the effects
reported in [41, 42] will not make the use of unadjusted power unreasonably conservative unless some of the covariates are
very highly associated with the outcome. If the triallist has adequate information on the relationship between covariates
and outcome then more sophisticated methods based on a postulated logistic model can be used[43]: this methodology
requires the evaluation of the information matrix at the alternative hypothesis. The approach in [43] uses an ingenious
conditioning argument so that only one-dimensional numerical integration is required. It is possible that the approach in
the present paper, using a probit approximation and the ESN distribution, could be used to go further and replace the
numerical integration with an accurate analytic approximation.
The comparison between logistic and probit analyses is interesting. If the parameter estimates from a logistic regression
are βˆ then the estimates obtained from fitting a probit regression to the same data will be approximately cβˆ, so the
corrections in (9) and (15) are essentially equal. However, if P not close to 1 or 0, Figure 1 shows that the asymptotic bias
α∗ can be greater than is implied by (9). However, the correction in (15) is an exact result, so it may be that the problem
of asymptotic bias in the estimates of the treatment effect are less if probit is preferred to logistic regression. A deeper
aspect of the analysis which may warrant further study is the extent to which trials with a binary outcome are best served
by either a logit or probit link. Both links provide protection against estimated probabilities outside [0,1], and sufficiency
arguments favour a logistic link, but both bring the problems of interpretation of the treatment effect discussed above. Gail
and colleagues [2] pointed out the superior bias properties of identity or log links, and perhaps methods of incorporating
baseline covariates into analyses of absolute differences of response probabilities should be given further consideration.
12 www.sim.org Copyright c© 0000 John Wiley & Sons, Ltd. Statist. Med. 0000, 00 1–16
Prepared using simauth.cls
J.N.S. Matthews and N.H. Badi
Statistics
in Medicine
Appendix
The Extended Skew Normal distribution
The density of an extended multivariate skew-Normal (ESN) random variable U ∈ Rp [12] is
f(u) =
φp(u;ω,Ω)Φ(ζ
T (u− ω) + ψ)
Φ(ψ/
√
1 + ζTΩζ)
, (17)
where ζ is a p-dimensional parameter, ψ is a scalar, φp(·;ω,Ω) is the p-dimensional multivariate Normal density with
mean ω and dispersion Ω and Φ(·) is the standard Normal distribution function. The mean of the ESN distribution is
E(U) = ω +
Ωζ√
1 + ζTΩζ
φ(ψ¯)
Φ(ψ¯)
,
where ψ¯ = ψ(1 + ζTΩζ)−
1
2 and φ(·) = φ1(·; 0, 1). From
∫
f(u)du = 1 we see than
∫
φp(u;ω,Ω)Φ(ζ
T (u− ω) + ψ)du =
Φ(ψ/
√
1 + ζTΩζ), with a similar manipulation giving
∫
ujφp(u;ω,Ω)Φ(ζ
T (u− ω) + ψ)du = ωjΦ(ψ¯) + (Ωζ)j√
1 + ζTΩζ
φ(ψ¯).
Least false values for logistic regression
Writing pt = Pr(T = t) and applying the approximation expit(u) ≈ Φ(cu) to (3), (4) and (5) and using the properties of
the ESN distribution, we obtain from (3) and (4) the equations
p1Φ(ψ
∗
1)± p−1Φ(ψ∗−1) = p1Φ(ψ1)± p−1Φ(ψ−1) (18)
and from (5) we obtain
p1[ν1Φ(ψ
∗
1) +
cΩ11β
∗
1√
1 + c2β∗T1 Ω11β
∗
1
φ(ψ∗1)] + p−1[ν−1Φ(ψ
∗
−1) +
cΩ11β
∗
1√
1 + c2β∗T1 Ω11β
∗
1
φ(ψ∗
−1)]
= p1[ν1Φ(ψ1) +
c(Ωβ)1√
1 + c2βTΩβ
φ(ψ1)] + p−1[ν−1Φ(ψ−1) +
c(Ωβ)1√
1 + c2βTΩβ
φ(ψ−1)]
(19)
Here βT = (βT1 , βT2 )T , (Ωβ)1 denotes the first p elements of Ωβ and
ψ∗1 =
c(µ∗1 + α
∗)√
1 + c2β∗T1 Ω11β
∗
1
ψ∗
−1 =
c(µ∗
−1 − α∗)√
1 + c2β∗T1 Ω11β
∗
1
ψ1 =
c(µ1 + α)√
1 + c2βTΩβ
ψ−1 =
c(µ−1 − α)√
1 + c2βTΩβ
with µ∗t = µ∗ + β∗T1 νt,1 and µt = µ+ βT νt, where νt,1 is written for the first p elements of νt. From (18) we obtain
ψ∗1 = ψ1 and ψ∗−1 = ψ−1, and using this in (19) we get
Ω11β
∗
1√
1 + c2β∗T1 Ω11β
∗
1
=
(Ωβ)1√
1 + c2βTΩβ
=
Ω11β1 +Ω12β2√
1 + c2βTΩβ
and these can be solved to give (6), (7) and (8).
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Owen’s T function
Owen’s T function, which appears in (13), is defined as
T (h, a) =
1
2pi
∫ a
0
exp[− 12h2(1 + x2)]
1 + x2
dx,
and has an important role in the computation of bivariate Normal probabilities. It can be evaluated conveniently by the
function T.Owen in the R package sn [44]. For fixed h, T (h, a) is an increasing function of its second argument and as,
in the present application 0 < a < 1, it follows that the expression for α∗ in (13) is always closer to 0 than α. For fixed
a, T (h, a)/T (h, 1) is an even function of h and increases as the magnitude of h increases, so the largest attentuation of α
occurs at h = 0. As the magnitude of h increases, T (h, a)/T (h, 1) approaches one, so α∗ approaches α.
Least false values for probit regression
The least false equations for the maximum likelihood estimators for a probit regression differ from (3) to (5) because of
the presence of a weighting factor ω = ω(T,X1) = ω(η∗) with η∗ = µ∗ + α∗T + β∗T1 X1, i.e. the p+ 2 equations are
E[ω(η∗)ZΦ(η∗)] = E[ω(η∗)ZΦ(µ+ αT + βT1 X1 + β
T
2 X2)] (20)
where ω(η∗) = φ(η∗)/[Φ(η∗)Φ(−η∗)], and where Z is taken to be, successively, 1, T andX1j , j = 1, . . . , p. The presence
of ω means that the skew-Normal distribution cannot be used to evaluate the expectations in the way it was used for logistic
regression, but it can be applied to evaluate the right hand expectation in (20) over the distribution of X2 conditional on T
and X1, giving
E

ω(η∗)ZΦ

µ+ β
T
2 (νT,2 − Ω21Ω−111 νT,1) + αT + (β1 +Ω−111 Ω12β2)TX1√
1 + βT2 Ω˜β2




Consequently, if we choose β∗1 , µ∗ and α∗ as in (6), (7) and (8) but with denominator
√
1 + βT2 Ω˜β2 as opposed to√
1 + c2βT2 Ω˜β2, then equations (20) will be satisfied.
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